The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.
Home » Clinical Trials » Clinical Trial Results Database
Clinical Trial Result Information
Title of Study:
A Comparison of the Effects of Aleglitazar and Actos® on Renal Function on Patients With Type 2 Diabetes.
Fast Facts:
| Protocol number: | BC20653 |
| Sponsor: | Hoffmann-La Roche |
| Company division: | Pharmaceutical |
| Product name: | aleglitazar |
| Phase of development: | II |
| Therapeutic area, approved indication: | Diabetes Mellitus, Type 2 |
| Date of report: | To be Published |
Clinical study summary:
This trial does not yet have clinical trial results posted on this website. All trial results will be posted within one year of approval or one year after trial completion, unless the release of information is restricted due to journal publication timing or pending regulatory filing. For further information on the timing of posting clinical trial results please consult the Roche policy for posting information on this website.
